Search Results for: cancer

For IPS cell mutations, some reassuring new data but validation still key

Figure-1b

Over the years some scientists including yours truly have expressed concerns about the possibility that mutations could crop up during the reprogramming process to make induced pluripotent stem cells (IPS cells or IPSC). How concerned should we be about IPS cell mutations? A cool new paper, Bhutani, et al, in Nature Communications from a team led by […]

For IPS cell mutations, some reassuring new data but validation still key Read More »

TGIF weekend reads: stem cells, GMOs, #CRISPR, cats, cloning and more

cat-stem-cells

Sounds recommended weekend reads for you to enjoy since it is Friday and almost the weekend including stem cells, CRISPR, cats, cloning, and more. Holy GMO, China wants to buy Syngenta. RetractionWatch says that Macchiarini will soon be out at Karolinska. For more on this “super surgeon” who used stem cells, see here regarding recent Vanity

TGIF weekend reads: stem cells, GMOs, #CRISPR, cats, cloning and more Read More »

Takeaways from new Yamanaka (山中伸弥) stem cell interview

Dr.-ShinyaYamanaka

Shinya Yamanaka is one of my favorite fellow scientists. His research is creative and rigorous along with having huge clinical implications. At the same time, Dr. Yamanaka sees the big picture and he’s very open about talking about real life as a scientist. I really appreciate both levels. In the past I interviewed him for

Takeaways from new Yamanaka (山中伸弥) stem cell interview Read More »

Perspectives: no human genetic modification moratorium from organizers of #GeneEditSummit

GeneEditSummit

I just got back from a historic summit on human genetic modification in Washington, D.C. New genetic modification technology, termed CRISPR-Cas9, has both made genetic modification a relatively simple matter for scientists and human genetic modification much more likely in the near future. Heritable human genetic modification could prevent some rare genetic diseases so there

Perspectives: no human genetic modification moratorium from organizers of #GeneEditSummit Read More »

Live Blogging #GeneEditSummit Day 1 Post #3: human germline modification

Robin-Lovell-Badge-Peter-Braude-George-Church

The post-lunch session is “Applications of Gene Editing Technology: Human Germline Modification”. Prior to hearing it I’m curious how cautious or gung-ho the speakers will be, or if their gestalt will be one of balance in the middle somewhere. Robin Lovell-Badge, The Francis Crick Institute, was the moderator of this session. He said, “We’d be

Live Blogging #GeneEditSummit Day 1 Post #3: human germline modification Read More »

Live Blogging #GeneEditSummit Day 1 Post #2: State of the Science, #CRISPR

Human-gene-editing-science-session-small

Now we hear from the scientists on the front lines of CRISPR, covered in this post #2 of the Human Gene Editing Meeting. You can read Post #1 here. Jennifer Doudna starts off the big human gene editing science session on the current state of the human gene editing science and CRISPR. She gave an

Live Blogging #GeneEditSummit Day 1 Post #2: State of the Science, #CRISPR Read More »

Claim of Liz Parrish DIY gene therapy linked to unlicensed stem cell clinic

Elizabeth-Parrish

In a strange, but fascinating tale recounted by Antonio Regalado in an article over at MIT Tech Review, we hear the first claim of a do-it-yourself (DIY) gene therapy involving a firm called BioViva and its leader Liz Parrish. Liz Parrish and BioViva The owner of a small biotech called BioViva, Liz Parrish, reportedly traveled

Claim of Liz Parrish DIY gene therapy linked to unlicensed stem cell clinic Read More »